As researchers progress towards clinically relevant processes ... to receive step-by-step guidance about optimizing and standardizing scalable lentiviral vector production and clarification.

The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at ...

They engineered an adenoviral vector to include a repressor protein ... other advantages over alternative ‘helper-free’ rAAV manufacturing systems. “For all the serotypes tested, we ...

Reports FY24 revenue GBP 128.8M vs. GBP 89.5M last year. Frank Mathias, CEO of OXB, commented: “2024 was a year of strong commercial progress for ...